"Grail's Multi-Cancer Blood Test Shows Promise in Large Study"
TL;DR
Grail, a blood testing company, presented the results of a large study at ASCO23, which showed that its commercial blood test, Galleri, could be used to diagnose patients suspected of having cancer due to symptoms such as abdominal pain, rectal bleeding, or unexplained weight loss. The test searches for the genetic fingerprints of cancer in the blood, and Grail hopes that doctors will consider it as an alternative to expensive scans or invasive biopsies.
Topics:healthhealthcare-technology#asco23#blood-test#cancer-diagnosis#galleri#grail#healthcare-technology
- Grail's blood test charts path for diagnosing patients suspected of having cancer in large study: #ASCO23 Endpoints News
- Blood test for more than 50 cancers 'shows promise' in study - BBC News BBC News
- Around 400 patients were wrongly informed they might have cancer, biotech company says Yahoo News
- GRAIL and University of Oxford to Present Results From First Prospective Study of Multi-Cancer... BusinessWire
- Newspaper headlines: Cancer 'game-changer' and 'tears for Phil' BBC
Want the full story? Read the original reporting
Read on Endpoints News